A variation of the Nijmegen-Bethesda assay using heat or a novel heat/cold pretreatment for the detection of FIX inhibitors in the presence of residual FIX activity-Reference-Cited by-同舟云学术

A variation of the Nijmegen-Bethesda assay using heat or a novel heat/cold pretreatment for the detection of FIX inhibitors in the presence of residual FIX activity

Published:2016-08-21 Issue:6 Volume:38 Page:639-647
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int. Jnl. Lab. Hem.

Author:

Millner A. H.¹,Tiefenbacher S.²,Robinson M.²,Boesen H. T.¹

Affiliation:

1. Immunogenicity Assessment; Novo Nordisk A/S; Måløv Denmark

2. Colorado Coagulation; Laboratory Corporation of America Holdings; Englewood CO USA

Funder

Novo Nordisk

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijlh.12552/fullpdf

Reference16 articles.

1. Health status and health-related quality of life of children with haemophilia from six West European countries;Gringeri;Haemophilia,2004

2. Inhibitor development in haemophilia B: an orphan disease in need of attention;DiMichele;Br J Haematol,2007

3. Monitoring inhibitor patients with the right assays;Barrowcliffe;Semin Hematol,2008

4. The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improved specificity and reliability;Verbruggen;Thromb Haemost,1995

5. Proceedings: a more uniform measurement of factor VIII inhibitors;Kasper;Thromb Diath Haemorrh,1975

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional determination of emicizumab in presence of factor VIII activity;Journal of Thrombosis and Haemostasis;2023-12

2. International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors;International Journal of Laboratory Hematology;2023-06-07

3. Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy;International Journal of Hematology;2022-05-03

4. Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey;Haemophilia;2021-03-02

5. Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients;Research and Practice in Thrombosis and Haemostasis;2020-07-29